Martin (Marty) Makary, MD, MPH is a gastro-intestinal/pancreas surgeon and public policy researcher at Johns Hopkins University. He is a prolific author, writing for The Washington Post and The Wall Street Journal, authoring of three New York Times bestselling books – Unaccountable, The Price We Pay and Blind Spots – and regularly commentating on CNN and Fox News. Dr. […]
Read more
Effective on October 21st of this year, the Federal Trade Commission (FTC) issued a new final rule that is intended to better combat “fake” reviews and testimonials by prohibiting the sale or purchase of “fake reviews” as well as granting the agency the opportunity to seek civil penalties against willful violators. The FTC made only […]
Read more Agencies with healthcare clients in pharmaceuticals, healthcare services, digital health apps, or health-related connected devices such as wearables should take note that the Federal Trade Commission (FTC) final rule updating its Health Breach Notification Rule (HBNR) that took effect on July 29, 2024. The FTC considers a breach to include a covered entity’s unauthorized disclosure […]
Read more The Federal Trade Commission (FTC) issued a final rule on April 26, 2024 that updates its Health Breach Notification Rule (HBNR). The final rule definitions now encompass health apps and other technologies not covered by the Health Insurance Portability and Accountability Act (HIPAA). It also specifies what the FTC considers a breach of security, new […]
Read more
The U.S. Department of Labor (DOL) recent released a modified employee overtime pay rules. The new rules which take effect on July 1, 2024 (with a secondary deadline of January 1, 2025) will have a material impact on many U.S. businesses including marketing service companies. Background The federal Fair Labor Standards Act (FLSA) guarantees minimum wages […]
Read more
April 24, 2024 @ 1 pm ET In conjunction with the release of a new 4A’s-CHC exclusive white paper – Navigating the Health Data Privacy Landscape – join us for a one-hour webinar as our speakers traverse the growing evolution of new laws and regulations attempting to regulate “HIPAA-adjacent” healthcare data, driven by the colossal growth of […]
Read more
As run-up to FDA’s DTC Prescription Advertising Rule that goes into effect on May 20, 2024, CHC is working with FDA staff to help reinforce current ad review processes available to healthcare marketers and how review of ads will change in May and later this year with its November enforcement date. Watch for our planned […]
Read more
Watch our 30-minute webinar on-demand that cover the FTC’s jurisdiction in the health privacy space and HIPAA-adjacent ad agencies and communications companies, as well as how the FTC prioritizes enforcement actions in the health privacy space. Gain insights on what the healthcare advertising industry can do better in terms of health privacy and what […]
Read more
WASHINGTON, DC – The Coalition for Healthcare Communication (CHC) has filed a federal court amicus brief that raises concerns about how the Federal Trade Commission (FTC) defined the “programmatic advertising” marketplace in its complaint against IQVIA’s proposed merger with Propel Media and offered its real-world insight into the industry, which span the entire digital “ad […]
Read more